ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit

TitleICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit
Publication TypeJournal Article
Year of Publication2003
AuthorsWheatley, K, Gray, R
JournalLancet
Volume362
Pagination1333; author reply 1334
KeywordsAntineoplastic Combined Chemotherapy Protocols/*administration & dosage/economics Cisplatin/administration & dosage Clinical Trials as Topic/economics/standards Cost-Benefit Analysis Female Humans Ovarian Neoplasms/*drug therapy/mortality Paclitaxel/admin